Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach

Fig. 3

Analysis of tumor growth, body weights and survival rates. (A) Treatment schedule. (B) Individual tumor growth curves of each animal treated with different substrates, including PBS, lysate, neoantigens, LN, CL, CN and CLN. (C) Tumor volumes were measured at indicated time-points and shown as average of duplicate measurements with standard error bars (n = 6 for each group). (D) The body weights of mice were measured at indicated time-points and shown as average of duplicate measurements with standard error bars (n = 6 for each group). (E) Survival curves of mice after various treatments

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us